Providing Today's Patients with Medicines of the Future
Simcere Project X, only for “daring explorers”!
Dec 29, 2022, Simcere Pharmaceutical Group (2096.HK) announced that the company has received Investigational New Drug (IND) approval from China Nation...
On Dec 23 , 022 , Tsinghua University and Simcere Pharmaceutical Group (2096.HK)today announced that they have signed a strategic collaboration agreem...
December 18, 2022, Simcere Pharmaceutical Group (2096.HK) announced today that, XIANNUOXIN (先諾欣TM, SIM0417), an anti-SARS-CoV-2 drug candidate jointly...
On Dec 1,2022,Simcere Pharmaceutical Group Ltd (2096.HK), announced that, a multi-center, randomized, double-blind, parallel and placebo-controlled ph...
Staff
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions